Effectiveness of three calcitonin gene-related peptide monoclonal antibodies for migraine: A 12-month, single-center, observational real-world study in Japan.
Keisuke SuzukiShiho SuzukiTomohiko ShiinaMuneto TatsumotoHiroaki FujitaYasuo HaruyamaKoichi HirataPublished in: Cephalalgia : an international journal of headache (2023)
This real-world study confirmed the efficacy and safety of three different CGRP mAbs for prophylactic treatment of patients with migraine.